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Summary 
Intestinal motility disorders are an important problem in horses and donkeys and this study 
was carried out in order to evaluate the enteric neurons in animals with and without intestinal 
disease.  Surplus intestinal tissue samples were collected from 28 horses undergoing 
exploratory laparotomy for colic.  In addition, surplus intestinal samples from 17 control 
horses were collected immediately following humane destruction for clinical conditions not 
relating to the intestinal tract.  Similar samples were also collected during routine post-
mortem examinations from 12 aged donkeys; six animals were humanely destroyed for 
conditions related to the intestinal tract, while the remaining six were humanely destroyed for 
other reasons including dental and orthopaedic diseases.  Tissue samples were fixed in 
formalin and immunohistochemical labelling was performed targeting the enteric neurons 
using a polyclonal antibody specific for the neuronal marker PGP 9.5. The distribution and 
density of neuronal networks were assessed qualitatively and semi-quantitatively.  There was 
strong PGP 9.5 expression in both the horse and donkey samples and labelling was detected 
throughout the tissue sections.  In both species, PGP 9.5-immunoreactive nerve fibres were 
detected in all layers of the intestinal tract, both in large and small intestinal samples. 
Networks of enteric neurons were present in the donkey with a similar distribution to that seen 
in the horse.  There was no demonstrable difference in enteric neuronal density and 
distribution in the groups of animals with intestinal disease compared with those without, 
apart from two (out of 28) horses with intestinal disease that showed a marked reduction in 
PGP 9.5 immunoreactivity.  Apart from these two animals, this total cohort analysis differs 
from some previously observed findings in horses with intestinal disease and may therefore 
reflect the different pathophysiological processes occurring in varying intestinal conditions 
resulting in colic both in the donkey and horse. 
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Introduction 
Disorders of the gastrointestinal tract are among the most common problems in equine 
medicine.  Colic (abdominal pain) is reported by insurance companies and universities as the 
single greatest killer of horses (White, 1990).  The incidence of colic in the horse has been 
reported as four to 10 cases per 100 horses per year (Tinker et al., 1997; Traub-Dargatz et al., 
2001; Archer and Proudman, 2006; Dukti and White, 2009).  The economic impact on the 
equine industry is significant with an annual estimated cost in the USA of over $115 million 
(Traub-Dargatz et al., 2001). 
Colic disorders also represent a significant problem in donkeys and impaction of the 
pelvic flexure of the large colon has been reported as the most common cause of colic in the 
UK donkey population (Cox et al., 2007).  That study also identified risk factors for 
developing impactions, which included old age and dental disease, as well as previous colic 
episodes (Cox et al., 2007).  Du Toit et al. (2008) further identified the presence of cheek 
teeth diastemata as a factor associated significantly with colic-related illness in the donkey. 
The precise cause of gastrointestinal dysfunction is often unknown in cases of colic 
(Archer and Proudman, 2006).  These syndromes may be linked to alterations in the motility 
control systems, namely the enteric nervous system, the interstitial cells of Cajal (ICC) and 
the intestinal smooth muscle.  Horses with chronic obstructive disorders of the large colon or 
recurrent caecal impactions have been shown to have reduced densities of neurons in the large 
colon or caecum (Schusser and White, 1997; Schusser et al., 2000).  Additionally, a reduction 
in ICC density has been demonstrated in the pelvic flexure of horses with large intestinal 
obstructive disorders, suggesting a possible involvement of ICC in equine intestinal 
dysmotility (Fintl et al., 2004).  Recently, a reduction in enteric neuronal activity and ICC 
immunoreactivity in cases of colic in horses has been reported (Pavone et al., 2012).  Finally, 
in donkeys, a recent study showed there was no difference in ICC density and distribution in 
animals with and without intestinal disease (Fintl et al., 2010a), but to the authors’ 
knowledge, investigation of the neuronal component of intestinal motility has not been 
evaluated previously in the clinical setting in this species.  
The aim of the present study was to compare the enteric neuronal profile in normal 
(free from intestinal disease) versus diseased animals (both horses and donkeys), using a 
neuronal immunohistochemical marker, protein gene product (PGP) 9.5. 
 
Materials and Methods 
Samples 
Intestinal samples were collected from all animals at anatomically-defined sites.  These were: 
the ileum (at a position level with the midpoint of the ileocaecal fold) and the apex of the 
pelvic flexure (located at the junction between the left ventral colon and left dorsal colon).  In 
some horse surgical cases, jejunum was collected from the non-ischaemic margin of the 
resected small intestine.  The differing numbers and age ranges of horse and donkey samples 
detailed below reflects the access to material from the two species in these clinical caseload 
settings. 
  
Horses.  Intestinal samples from 17 control horses were collected immediately (within 1 h) 
after humane destruction for clinical conditions not relating to the intestinal tract.  The ages of 
the animals in this group ranged from 1–33 years (median 11.0 years, mean 12.3 years) and 
these animals comprised of one stallion, 11 geldings and five mares.  The samples collected 
included a section of ileum and/or pelvic flexure as described.  It was not always possible to 
obtain both ileal and pelvic flexure samples from all horses included in this study, so a total of 
12 ileal and eight pelvic flexure control samples were collected (Table 1).  The small 
intestinal control group ranged in age from 1–33 years (median 11.5 years, mean 13.5 years) 
and comprised of one stallion, eight geldings and three mares, while the large intestinal 
control  group comprised of one stallion, five geldings and two mares with an age range of 1–
19 years (median 6.5 years, mean 8.0 years).  
In addition, intestinal tissue samples were collected from 28 horses undergoing 
exploratory laparotomy for the evaluation and treatment of colic (Table 1).  The age range of 
this group was 2–24 years (median 11.0 years, mean 11.0 years) and it comprised of 14 
geldings and 14 mares.  Small intestinal tissue sections were obtained from the non-ischaemic 
margin of resected small intestinal tissue from nine horses with an obstructive lesion of this 
anatomical region.  The samples collected included jejunum (n = 4) or ileum (n = 5).  Every 
effort was made to collect samples that were similar or as close to the anatomical site of the 
control animals as possible.  The age range of this group was 7–24 years (median 14.0 years, 
mean 14.8 years) and it consisted of six geldings and three mares.  In addition, samples of 
pelvic flexure collected from 19 horses with a large colon obstructive disorder were evaluated. 
The samples evaluated were all surplus tissue following a pelvic flexure apex biopsy 
submitted for histological analysis and collected during an enterotomy procedure prior to 
large colon evacuation.  The age range of this group was 2–24 years (median 9.0 years, mean 
9.3 years) and it consisted of eight geldings and 11 mares.   
The animals in this study included material from 39 horses from previous 
immunohistochemical and molecular studies of ICC (Fintl et al., 2004, 2010b).  Samples from 
six additional horses were included.  The reason for including horses from previous studies 
was to obtain a higher collective sample number, as there was not always enough tissue 
available to be used in all immunohistochemical studies.  This was particularly true for the 
large colon colic samples, which were all surplus material following a pelvic flexure apex 
biopsy.  In addition, this current study evaluated a different component of the intestinal 
motility control system, namely the enteric neurons.  Samples were from horses admitted to 
the equine hospitals at the Universities of Edinburgh and Liverpool and were collected with 
the informed, written consent of the owners. 
 
Donkeys.  Intestinal tissue samples were collected from 12 donkeys following routine post-
mortem examinations.  In seven animals, humane destruction was related to clinical signs 
indicating an abdominal problem, while in the remaining five donkeys, other conditions were 
diagnosed (Table 2).  All animals were subsequently grouped into either the control group 
(i.e. animals that following post-mortem examination were determined not to have intestinal 
disease) or into the disease group (animals with an intestinal disorder).  All donkeys were 
aged 26–35 years (median 28 years, mean 29.5 years) and the population consisted of one 
stallion, seven geldings and four mares.  The age range of the control group was 26–32 years 
(median 27 years, mean 28.1 years) and this group comprised of two geldings and four mares. 
The age range for the colic group was 27–35 years (median 27.5 years, mean 30.3 years) and 
it comprised of one stallion and five geldings.  One animal (donkey 6) was humanely 
destroyed on the basis of displaying clinical signs of colic, but was subsequently diagnosed 
post mortem to have a chronic liver problem (Table 2).  As a consequence, this animal was 
included in the control group rather than in the intestinal disease group.  All animals with a 
suspected abdominal problem had been treated medically (including with oral laxatives, oral 
or intravenous fluid therapy and analgesic drugs).  However, as these treatments failed to 
resolve the problem, the decision was taken to humanely destroy the individual animals rather 
than to pursue further treatment such as exploratory abdominal surgery. The latter was not 
considered to be in the animals’ best interests, primarily due to their advanced age and general 
physical condition, which rendered them poor surgical candidates.  
A segment of ileum (level with the midpoint of the ileocaecal fold) and a sample of the 
pelvic flexure (from the junction of the left ventral colon and left dorsal colon) were collected 
and then analyzed from all animals apart from donkeys 9 and 10 where only a section of 
pelvic flexure was analyzed and donkey 4 where only ileum was analyzed.  As with the horse 
studies, 12 of the samples were collected from animals used in a previous 
immunohistochemical study of ICC (Fintl et al., 2010a), which, as mentioned above, 
evaluated a different component of the intestinal motility control system.  The post-mortem 
examination performed in all animals included assessment of their teeth (Fintl et al., 2010a). 
All samples were collected with the permission of, and in collaboration with, The Donkey 
Sanctuary, Sidmouth, Devon, which owned all of the donkeys included in the study.  
 
Histology and Immunohistochemistry 
Samples were fixed in 10% phosphate buffered formalin for at least 24 h.  Tissue processing 
consisted of rinsing the tissue samples in running tap water for 1 h prior to placing them in 
graded sucrose solutions (10% and 30% sucrose in phosphate buffered saline) in order to 
cryoprotect the samples.  The samples were frozen rapidly in isopentane (BDH Laboratory 
Supplies, Poole, UK) pre-cooled in liquid nitrogen or dry ice and subsequently sectioned (10 
m).  All sections were mounted on Tespa-coated (3-aminopropyltriethoxysilane; Sigma 
Aldrich, Poole, UK) slides and allowed to air dry overnight.  After washing the sections in 
phosphate buffered saline (PBS), they were incubated for 30 min in H2O2 0.3% in methanol in 
order to quench endogenous peroxidase activity.  The sections were then incubated for 1 h in 
1% goat serum (Vector Laboratories, Burlingame, California, USA) in order to block non-
specific antibody binding.  After subsequent washes with PBS, the sections were incubated 
overnight at 4C in a humid chamber with rabbit polyclonal antiserum specific for PGP 9.5 
(UltraClone, Wellow, Isle of Wight, UK), at a concentration of 1 in 8,000.  The tissue sections 
were then washed with PBS prior to a 1 h incubation with biotin-conjugated goat anti-rabbit 
immunoglobulin (Vector Laboratories) at a concentration of 1 in 200.  Labelling was 
‘visualized’ using the avidin–biotin method (ABC; Vectastain Elite ABC Kit, Vector 
Laboratories) with a 3, 3’ diaminobenzidine substrate (DAB; BDH Laboratory Supplies). 
Sections were dehydrated in ethanol, cleared in xylene and then mounted under DPX (Merck, 
Glasgow, UK). 
For all batches processed, both negative and positive controls were included.  In 
negative controls, the primary antibody was replaced with normal rabbit serum. This resulted 
in the complete absence of immunolabelling.  Positive controls were based on the use of tissue 
from normal control animals in which abundant immunoreactivity for PGP 9.5 had been 
demonstrated previously.  
All samples were evaluated in blinded fashion on two occasions (1 week apart) by one 
observer (CF) similar to the technique described by Prince et al. (2003).  A semiquantitative 
grading system, as described for previous equine ICC studies (Hudson et al., 2001; Fintl et al., 
2004), was used and modified for this study. The grades given were based on the scrutiny of 
four adjacent 10 μm tissue sections from each sample from each animal.  PGP 9.5 
immunoreactivity was graded as absent (grade 0), sparse (grade 1), moderate (grade 2) or 
abundant (grade 3).  Immunoreactivity of the myenteric plexus region and circular muscle was 
evaluated separately.  Where mucosa was included in the sections, immunoreactivity of this 
region was also evaluated; this involved assessment mucosal nerve (including fibre) density.  
Depending on the size and thickness of the original tissue section, it was not always possible 
to obtain complete full-thickness samples in all animals for this study.  A Mann–Whitney test 
assuming a significance level of 5% was used when analyzing the data.  Variability between 
the grades given on the two separate occasions was also assessed using the same statistical 
method. 
In addition to immunohistochemical labelling, all processed tissues were stained with 
haematoxylin and eosin (HE) in order to assess tissue integrity.  This was performed to help 
clarify whether reduced or absent immunoreactivity was a primary finding or secondary to a 
degree of tissue autolysis.  Only samples with good tissue integrity (and not worse than a mild 
degree of mucosal degradation) were included in order to ensure that immunohistochemical 
grading was reliable.  As no significant degree of tissue autolysis was present in any of the 
samples collected, all were included in the study. 
 
Results 
There was strong expression of PGP 9.5 in the horse and donkey samples and this was 
detected throughout the tissue sections.  In the horse, PGP 9.5-immunoreactive nerve fibres 
were detected in all layers of the intestinal tract, both in large and small intestinal samples. 
Ganglia were observed in the submucosal and myenteric plexuses.  In the mucosa, lamina 
propria and muscularis mucosa the enteric neuronal axons were clearly evident, forming a 
dense network and, in the ileal samples, these extended into the mucosal villi (Fig. 1). 
Immunoreactive axons were also observed in the submucosa as well as the circular and 
longitudinal smooth muscle layers; with the nerve fibres generally having an orientation that 
was parallel to the muscle fibres and uniformly distributed throughout the muscle layers (Figs. 
2 and 3).  Ganglia were observed both in the submucosal and myenteric plexus regions.  The 
tissue sections were cut in a plane parallel to the orientation of the circular muscle fibres, with 
the longitudinal muscle layer presenting in transverse section.  However, it was sometimes 
difficult to obtain true parallel sections, especially in the smaller pelvic flexure biopsy 
samples.  Therefore, in a number of slides the nerve fibres would have been transected, 
thereby showing a punctuate positivity rather than a parallel linear positive reaction.  Despite  
this, it was still possible to estimate the degree of immunoreactivity due to the strong 
immunolabelling this antibody provides.  The size and number of ganglionic collections of 
neurons varied, with the size being clearly dependent on the angle of section.  However, the 
ganglia observed in the myenteric plexus were larger and more numerous than those observed 
in the submucosal region.  Again, because of the angle of sectioning, it was not possible to 
reliably count the individual cell bodies within the ganglia.  Because only a limited amount of 
tissue was available and this did not always include mucosa, the PGP 9.5 density in this 
region could not be assessed in all cases.  Owing to the clinical nature of the study (i.e. 
collection of clinically-derived tissues), it was considered reasonable to assess the samples 
without mucosa as being viable, since none of the samples collected in a similar fashion that 
included mucosa showed significant signs of autolysis.  In addition, these samples showed no 
preservation-related abnormalities in the other intestinal layers. 
In the donkeys, similar patterns of PGP 9.5 immunoreactivity were observed 
throughout the intestinal layers, both in large and small intestinal samples.  In the myenteric 
plexus region there was also an immunoreactive band of axons between the ganglia (Fig. 4). 
This differed from that observed in the submucosa where only individual ganglia were 
observed (Fig. 5).  A subtle subjective difference between donkey and horse PGP 9.5 
immunoreactivity was that the donkey nerve networks (fibres and ganglia) appeared more 
delicate in nature.  Both in horses and donkeys, there was evidence of strong PGP 9.5 
immunoreactivity even with increasing age of the animals.  
Comparison was made between normal and diseased animals with respect to the PGP 
9.5-immunoreative neuronal profiles.  In the horse study, the PGP 9.5 density was assessed 
and compared in the mucosa, circular muscle layer and the myenteric plexus of both the ileum 
and pelvic flexure in normal and diseased animals. The P values for these analyses are shown 
in Table 3.  
As seen from these data, there was no significant difference in the PGP 9.5 density in 
any of the anatomical areas in either of the groups.  There were no animals with absent 
immunoreactivity, although two animals with a large colon obstructive disorder had markedly 
reduced immunoreactivity throughout the pelvic flexure tissue sample, which was in stark 
contrast to the majority of normal and diseased horses. There was no significant difference in 
the grades given by the observer on the two separate occasions (P = 0.80) indicating good 
grading consistency. 
Similar observations were made in the donkey groups (Table 4).  No significant 
difference was observed in the density of PGP 9.5 immunoreactivity in the myenteric plexus 
region between the small intestinal samples collected from diseased animals and those of the 
controls.  Similarly, there was no significant difference in the density of PGP 9.5 
immunoreactivity observed in the circular muscle layer or the mucosa between these two 
groups.  Equally, in the donkey large intestine, there was no significant difference in the 
density of PGP 9.5 immunoreactivity in the myenteric plexus region or the circular muscle 
layer between control and diseased animals in the pelvic flexure samples.  Similarly, there 
was no significant difference in the density of PGP 9.5 immunoreactivity of the mucosa 
between these two groups.  It is worth re-emphasising here that although small intestinal 
samples from animals with a large colon impaction were evaluated, there was no evidence of 
systemic intestinal disease in these donkeys. This evaluation was merely performed for 
comparative purposes.  
As for the horses, there was good consistency (i.e. little variation) in the grades 
allocated to the donkey tissue sections on the two separate occasions these were evaluated (P 
= 0.34). 
Histological examination revealed all samples to be of sufficient quality to be included 
in the study.  Both in the horse and donkey samples, a mild to moderate degree of mucosal 
and submucosal lymphocytic infiltration was evident in a number of samples and modest 
numbers of eosinophils were observed.  These inflammatory cells did not appear to extend 
into the muscularis externa, apart from in the horse large intestinal colic cases where there 
was a mild perivascular lymphocytic infiltrate and occasional migrating neutrophils in this 
layer.  Although not assessed quantitatively or semiquantitatively, there did not appear to be a 
difference between diseased and control animals with respect to these mild cellular infiltrates. 
 
 
Discussion 
This study compared the density of PGP 9.5 immunoreactivity in samples from normal and 
diseased horses and donkeys as part of investigations into the possible causes of intestinal 
motility disorders in equids.  Two previous studies have demonstrated a significant reduction 
in myenteric neuronal densities in horses with chronic obstructive disorders of the caecum and 
large colon (Schusser and White, 1997; Schusser et al., 2000).  These investigators proposed 
that the changes observed were linked to the intestinal motility disorders of these animals 
(Schusser and White, 1997; Schusser et al., 2000).  In addition, a reduction in neurons of the 
enteric nervous system has been described in the dysautonomia of equids, grass sickness 
(Doxey et al., 1992).  These previous studies were carried out using histopathological 
evaluation of the tissue samples.  
Investigators have also evaluated PGP 9.5 as a neuronal marker in human intestinal 
motility disorders.  This protein is involved in the ubiquitin–proteasome system, which is a 
major pathway for selective protein degradation (Hershko and Ciechanover, 1992), thereby 
forming an essential part of the normal cellular processes in the cells where it is present.  The 
human disorders where this protein has been used as part of the investigation include 
conditions such as Hirschprung’s disease (Sams et al., 1992; Oh et al., 2002) and idiopathic 
megarectum and megacolon (Gattuso et al., 1996, 1997).  These studies demonstrated a 
significant reduction in labelled neurons in the affected areas of intestine as well as 
documenting that PGP 9.5 provides a reliable and sensitive means of identifying neurons in 
the intestinal tract (Sams et al., 1992; Gattuso et al., 1996, 1997; Oh et al., 2002).  PGP 9.5 
has also been shown to be a useful general marker for enteric neurons in recent horse studies, 
both in health and disease (Milne et al., 2005; Chiocchetti et al., 2009a, b).  
The subtle subjective difference observed between donkey and horse PGP 9.5 
immunoreactivity was interesting.  This may reflect a difference between the two species, but 
it is important to acknowledge the more geriatric nature of the donkey cases compared with 
the horse cases, which may or may not have had an effect.  This reflects the access to clinical 
material in these respective caseloads.  There has been some research on changes that occur in 
the ageing intestine, interest possibly stimulated by the increased life expectancy of people 
and the concomitant medical issues that may emerge.  Neuronal loss in the myenteric plexus, 
as well as neuromuscular dysfunction, has been demonstrated to occur with human ageing 
(Hall, 2002; Hanani et al., 2004).  In a study involving horses up to 20 years of age, Doxey et 
al. (1995) found no decline in the number of small intestinal enteric neurons with increasing 
age.  Additionally, Schusser and White (1997) found no significant difference in colonic 
neuronal density in normal horses that were 8 years old or less compared with animals over 8 
years old.  In this present study there was strong immunoreactivity for PGP 9.5 with 
advancing age in both species.  Ideally, future studies should evaluate the enteric nervous 
system in younger donkeys, but the nature of clinical studies means that it is often only tissue 
from older donkeys that is available. 
In the current study, there was no overall significant reduction in the neuronal densities 
in the groups of normal versus diseased animals.  However, there were two horses with a large 
colon obstructive disorder (left and right large colon displacement, respectively) that did have 
a marked reduction in PGP 9.5 immunoreactivity.  Interestingly, one of these horses had a 
history of previous colic episodes including surgery (for the same lesion, a right large colon 
displacement) and it seems reasonable to speculate that this could be part of the disease 
process as proposed by Schusser et al. (2000).  These two horses also had a significant 
reduction in ICC density that could also have contributed to the motility problems.  In 
examining the pathophysiology of equine intestinal dysmotility it can be difficult to ascertain 
whether a finding such as a change in intestinal cellular profile is a primary cause of the 
syndrome or an effect due to the intestinal disease process itself.  If the change observed is 
primary, it does beg the question as to whether certain animals are predisposed to developing 
signs of colic and ileus because of this characteristic.  As mentioned above, it has been 
suggested that the reduction in enteric neurons in horses with chronic large intestinal lesions 
may be a predisposing cause of colic in these animals (Schusser and White, 1997; Schusser et 
al., 2000).  Conversely, in the horse study of Pavone et al. (2012), it was suggested that the 
enteric nervous system and ICC changes observed may have been secondary to the colic 
episodes.  Fintl et al. (2004) suggested that the ICC changes in horse large intestinal 
obstructive disorders may have been a possible cause rather than effect of the colic episodes. 
Such disparate findings may simply reflect the difficulties of large animal clinical research 
studies.  By their very nature, studies of colic in equids often encompass heterogeneous 
disorders, making direct comparisons difficult.  It is possible that different case cohorts in the 
various studies may encompass disease processes with differing pathophysiology that may or 
may not directly damage cellular components such as ICC or neurons.  In addition, different 
studies often evaluate facets of the intestinal motility control system using different 
methodological approaches, such as alternative antibodies raised against neural elements or 
different stains, again hindering direct comparison.   Furthermore, it should be recognized that 
colic is a multifactorial syndrome (Archer and Proudman, 2006); intestinal cellular profiles 
may have a role, but also factors such as management and dental disease (to name but two) 
may be important.  In the donkeys in the current study there were no animals with a marked 
reduction in neuronal density in either of the two groups, suggesting that disruptions to the 
enteric neurons were not involved in the disease process.  The poor dental condition of most 
of the donkeys in the current study has been documented previously (Fintl et al., 2010a) and it 
is plausible that this may have been a contributing factor to the development of colic in the 
affected animals, rather than disruption to the enteric neurons and ICC which appeared 
normal.  
In conclusion, it appears that the general distribution and density of enteric neurons in 
the donkey are very similar to that of the horse.  PGP 9.5 is a useful general enteric neuronal 
marker in the horse and donkey and it was also able to reveal strong immunoreactivity in 
older animals.  It was not possible to demonstrate significant changes in enteric neuronal 
densities in the groups of animals with intestinal disease compared with the control groups, 
apart from two diseased horses (out of 28 with intestinal disease) where there was a reduction 
in PGP 9.5 immunoreactivity.  Apart from these two animals, this total cohort finding differs 
from some previously observed findings in horses with intestinal disease and may therefore 
reflect the different pathophysiological processes occurring in varying intestinal conditions 
resulting in colic in the donkey and horse. 
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Figure Legends 
 
Fig. 1.  PGP 9.5 immunoreactivity in the mucosa and submucosa of the ileum of a control 
horse.  Immunoreactivity is present in nerve fibres (arrows) and a submucosal ganglion 
(asterisk).  Nerve fibres can be seen in networks (arrows) extending into the mucosal villi. 
 
 
Fig. 2.  PGP 9.5 immunoreactivity in the pelvic flexure of a control horse.  Arrows indicate 
labelled nerve fibres. LM, longitudinal muscle layer; CM, circular muscle layer; MG, 
myenteric ganglion. 
 
Fig. 3.  PGP 9.5 immunoreactivity in the pelvic flexure of a horse with an obstructive large 
colon disorder.  Arrows indicate labelled nerve fibres. LM, longitudinal muscle layer; CM, 
circular muscle layer; MG, myenteric ganglion. 
 
Fig. 4.  PGP 9.5-immunoreactive nerve fibres and ganglia (asterisks) in the myenteric plexus 
region of the ileum of a control donkey.  LM, longitudinal muscle layer; CM, circular muscle 
layer. 
 
Fig. 5.  PGP 9.5 immunoreactivity in the mucosa and submucosa of the ileum of a control 
donkey.  Immunoreactivity is present in nerve fibres (arrows) and a submucosal ganglion 
(asterisk).  Nerve fibres can be seen in networks (arrows) extending into the mucosal villi.  
 Table 1  
Details of horses in the study 
Animal Age 
(years) 
Sex Clinical 
diagnosis 
Sample 
collected 
Previous colic 
episodes 
Controls      
1 4 MN Lameness Il/ PF No 
2 11 MN Lameness Il/ PF No 
3 1 M Lameness Il/ PF No 
4 12 MN Lameness Il No 
5 16 F Lameness Il No 
6 11 MN Lameness Il No 
7 33 MN Lameness Il No 
l 8 18 F Reproductive 
problems 
Il No 
9 12 F Lameness Il No 
10 6 MN Lameness Il No 
11 7 MN Lameness Il No 
12 31 MN Cardiac dysfunction Il No 
13 19 MN Lameness PF No 
14 3 MN Lameness PF No 
15 15 F Lameness PF No 
16 9 MN Lameness PF No 
17 2 F Neurological problem PF No 
SI Colic      
1 7 MN EFE Il No 
2 12 MN EFE Il No 
3 24 F Lipoma Jej No 
4 14 MN Meckel’s 
diverticulum 
Jej No 
5 8 F Mesenteric rent Jej No 
6 12 MN Eosinophilic Il No 
7 19 MN Lipoma Il No 
8 14 MN EFE Il No 
9 24 F Lipoma Jej No 
LI Colic      
10 6 MN RLCD PF Yes + Surgery 
11 5 MN RLCD PF Yes + Surgery 
12 3 F PFI (SI) PF Yes + Surgery 
13 24 MN PFI (SI) PF Yes 
14 11 F PFI (SI) PF Yes 
15 14 F LCT PF No 
16 11 F LCT PF No 
17 17 F LCT PF No 
18 12 MN LCT PF No 
19 4 MN RLCD PF No 
20 14 F LCT PF Yes + Surgery 
21 5 MN LLCD PF No 
22 11 F RLCD PF No 
23 11 MN RLCD PF No 
24 5 F LLCD PF Yes 
25 9 F LLCD PF No 
26 9 MN LCT PF No 
27 2 F LLCD PF No 
28 3 F LLCD PF No 
 
SI, small intestine; LI, large intestine; F, female; M, male; MN, male neutered; Il, ileum; Jej, jejunum: PF, pelvic 
flexure; EFE, epiploic foramen entrapment; Eosinophilic, focal strangulating eosinophilic lesion; PFI (SI), pelvic 
flexure impaction (sand impaction); LCT, large colon torsion; LLCD, left large colon displacement; RLCD, right 
large colon displacement 
 
 
Table 2 
 Details of donkeys in the study 
 Animal Age 
(years) 
Sex Reason for humane 
destruction 
Final diagnosis 
Control 
group 
1 32 F Lame Laminitis 
2 26 MN Neurological signs Unknown 
3 31 MN Dental Dental 
4 28 F Renal failure Nephrosis 
5 26 F Respiratory signs Pneumonia 
6 26 F Colic CLF 
Colic group 7 27 MN Weight loss PFI 
8 35 MN Colic PFI 
9 33 M Suspected liver disease PFI 
10 32 MN Weight loss PFI 
11 28 MN Distended abdomen PFI 
12 27 MN Distended abdomen PFI 
F, female; M, male; MN, male neutered; PFI, pelvic flexure impaction; LI colic, large intestinal colic; CLF, 
chronic liver fibrosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table 3  
 
P-values for comparison of PGP 9.5 density grades in normal and diseased horses 
 
 
 Normal versus 
diseased 
small intestine 
lesion 
Normal versus 
diseased 
large intestine lesion 
Mucosa 0.63 0.11 
Circular muscle layer 0.34 0.19 
Myenteric plexus 0.84 0.97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4 
 
 P-values for comparison of PGP 9.5 density grades in normal and diseased donkeys 
 
 
 Normal versus small 
intestine from 
animals with large 
intestinal disease 
Normal versus 
diseased 
large intestine  
Mucosa 0.06 0.64 
Circular muscle 
layer 
0.38 0.17 
Myenteric plexus 0.19 0.34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: PGP 9.5 immunoreactivity in the mucosa and submucosa of the ileum of a control 
horse.  Immunoreactivity is present in nerve fibres (arrows) and a submucosal ganglion 
(asterisk).  Nerve fibres can be seen in networks (arrows) extending into the mucosal villi. 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: PGP 9.5 immunoreactivity in the pelvic flexure of a control horse. Arrows indicate 
labelled nerve fibres. LM: longitudinal muscle layer; CM: circular muscle layer; MG: 
myenteric ganglion. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: PGP 9.5 immunoreactivity in the pelvic flexure of a horse with an obstructive large 
colon disorder. Arrows indicate labelled nerve fibres. LM: longitudinal muscle layer; CM: 
circular muscle layer; MG: myenteric ganglion. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: PGP 9.5-immunoreactive nerve fibres and ganglia (asterisks) in the myenteric plexus 
region of the ileum of a control donkey.  LM: longitudinal muscle layer; CM: circular muscle 
layer. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: PGP 9.5 immunoreactivity in the mucosa and submucosa of the ileum of a control 
donkey.  Immunoreactivity is present in nerve fibres (arrows) and a submucosal ganglion 
(asterisk).  Nerve fibres can be seen in networks (arrows) extending into the mucosal villi.  
 
 
 
